Free Trial

Ilya Zubkov Analyst Performance

Analyst at Freedom Broker

Ilya Zubkov is a stock analyst at Freedom Broker in the healthcare sector, covering 7 publicly traded companies. Over the past year, Ilya Zubkov has issued 12 stock ratings, including buy and hold recommendations. While full access to Ilya Zubkov's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Ilya Zubkov's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
14 Last 1 Years
Buy Recommendations
25.00% 1 Buy Ratings
Companies Covered
7 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy25.0%1 ratings
Hold75.0%3 ratings
Sell0.0%0 ratings

Out of 4 total stock ratings issued by Ilya Zubkov at Freedom Broker, the majority (75.0%) have been Hold recommendations, followed by 25.0% Buy.

Best & Worst Calls

This analyst does not have any ratings with enough history to determine best and worst calls.

Exchange Coverage

ExchangePercentageCount
NYSE
57.1% of companies on NYSE
4 companies
NASDAQ
42.9% of companies on NASDAQ
3 companies

Ilya Zubkov, an analyst at Freedom Broker, currently covers 7 companies listed on NYSE and NASDAQ, with the majority traded on NYSE.

Coverage Focus

Sector IconSectorPercentage
Healthcare
7 companies
100.0%

Ilya Zubkov of Freedom Broker specializes in stock coverage within the Healthcare sector.

Coverage Industries

IndustryPercentage
PHARMACEUTICALS
3 companies
42.9%
BIOTECHNOLOGY
2 companies
28.6%
HEALTHCARE PROVIDERS & SERVICES
1 company
14.3%
HEALTHCARE EQUIPMENT & SUPPLIES
1 company
14.3%

Ilya Zubkov's Ratings History at Freedom Broker

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
0 Results
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
11/2/2026Boost Price Target$148.58$140.00Hold
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
10/21/2026Downgrade$259.42Hold
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
8/3/2026Reiterated Rating$256.52Buy
LifeMD, Inc. stock logo
LFMD
LifeMD
3/12/2026Set Price Target$3.88$10.00
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
3/3/2026Set Price Target$15.87$25.00
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
3/2/2026Set Price Target$3.80$5.50
BioMarin Pharmaceutical Inc. stock logo
BMRN
BioMarin Pharmaceutical
3/2/2026Set Price Target$60.10$105.00
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
2/10/2026Set Price Target$1,025.06$1,200.00
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
1/27/2026Set Price Target$225.13$220.00
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
12/31/2025Set Price Target$3.82$5.00
LifeMD, Inc. stock logo
LFMD
LifeMD
11/24/2025Set Price Target$3.97$8.00
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
11/10/2025Set Price Target$968.80$950.00
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
10/22/2025Set Price Target$193.32$190.00Hold
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
10/22/2025Set Price Target$193.32$190.00